KronoLife has successfully developed ZenoLase Complex, a natural bioactive compound designed to target senescent cells. It demonstrates efficacy comparable to compounds studied in oncology research, while maintaining a high safety profile at food-grade level, making it suitable for health and beauty applications.
In addition to its senolytic properties, ZenoLase Complex exhibits anti-inflammatory and antioxidant activity, enhances skin radiance, and supports collagen and hyaluronic acid synthesis without causing irritation or allergic reactions. Comparative studies against eight leading international anti-aging actives showed that ZenoLase Complex delivered the most outstanding performance in targeting senescent cells and supporting longevity-related outcomes.
Building on this foundation, KronoLife developed the cosmeceutical innovation AGE-Reversal Senolytic Bright Serum, formulated with Triplex Biopeptides—three purified peptides clinically evaluated for enhancing brightness, reducing acne occurrence, and calming inflammation. These peptides work synergistically with ZenoLase Complex without compromising its senolytic mechanism.
This research and development milestone reflects KronoLife’s commitment to advancing Longevity Science through scientifically validated innovation, and represents a key factor behind the recognition received at the international stage.